Global Excellence in Experimental Pharmacology and Drug Discovery 2022: North America

41.8K

views

79

authors

9

articles

Global Excellence in Experimental Pharmacology and Drug Discovery 2022: North America

41.8K

views

79

authors

9

articles

Editors

3

Owen Chan

The University of Utah

Tao Hu

Evergreen Therapeutics, Inc.

Orsola di Martino

Washington University in St. Louis

Impact

About

Global Excellence in Experimental Pharmacology and Drug Discovery: North America

Global collaboration is the cornerstone of scientific advancement.

You can see our other collections within the series:
Global Excellence in Experimental Pharmacology and Drug Discovery: Africa
Global Excellence in Experimental Pharmacology and Drug Discovery: Europe
Global Excellence in Experimental Pharmacology and Drug Discovery: Australia and Asia

Frontiers in Experimental Pharmacology and Drug Discovery has organized a series of special edition Research Topics, with the goal of highlighting the latest advancements in Experimental Pharmacology and Drug Discovery across the globe, showcasing the academic excellence and high-quality work of internationally recognized researchers.

These collections aim to shed light on the recent progress made across the entire breadth of the Experimental Pharmacology and Drug Discovery field, and reflect on the future challenges faced by researchers across borders.

This Research Topic welcomes original research and review articles covering, but not limited to, the following topics from North America:

1. Mechanisms of drug action by analysis of interactions with receptors and/or specific biological targets e.g. enzymes, ion channels, transporters, transcription factors etc.

2. Drug-biomolecule interaction analysis including binding, transduction mechanisms, physiological responses, and pharmacokinetics,

3. Modern drug discovery including small molecules and biopharmaceuticals e.g. target identification (high-throughput) screening and other lead-finding techniques

4. Pharmacological research of new agents, novel pharmacodynamic and pharmacokinetic mechanisms as well as drugs already in use (e.g. treatment of diabetes, infectious disease, cardiovascular disease, cancer etc.)

Please note, that contributions to the collection are by invitation only. Please inform the Editorial Office once you are prepared to submit.

Share

Editors

Owen Chan

The University of Utah

Tao Hu

Evergreen Therapeutics, Inc.

Orsola di Martino

Washington University in St. Louis

Impact

41,785 Total views

18,849 Article views

6,835 Article downloads

16,101 Topic views

Published In

Frontiers in Pharmacology

Experimental Pharmacology and Drug Discovery

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic